Arrowhead Pharmaceuticals stock could build on its rally in the third quarter, Morgan Stanley says.

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced the first patient has been dosed in multiple Phase II studies of ...

Featured In Biomedwire Editorial Highlighting Biotech's Shift Toward Science-Driven Asset Valuation. Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage ...

TheFly reported on April 7 that Jefferies lowered its price target on ABUS from $7.00 to $5.50 while maintaining a Buy rating ...

Nanomedicine prompts RNA to make protein-based drugs to treat diseases. Now we can fine-tune protein production by dialling ...

If CRISPR stays active too long, it could cut unintended parts of the genome. To reduce this risk, the researchers designed a self-inactivating CRISPR system. This means that CRISPR edits the gene and ...

Internationally-renowned scientist Professor Greg Hannon, who led the Cancer Research UK (CRUK) Cambridge Institute for more ...

A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

Over the past decade, improved understanding of the physiological and molecular pathology of the cardiovascular system has ...

A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood ...

Cassava farmers on the Coast will soon plant superiorvarieties of the crop that are high-yielding and highly resistant to virusesthat blight cassava. The Kenya Agricultural and Livestock Research ...